AzTrials
AzTrials

Stroke, IschemicMOSENCT03530358

MOdularity for SEnsory Motor Control

A study testing Technology-aided rehabilitation and Conventional rehabilitation in people with Stroke, Ischemic and Upper Limb Injury, run by IRCCS San Camillo, Venezia, Italy at 2 sites in Italy.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

For this project the investigators ask, how the activation and organization of muscle synergies may be disrupted by brain lesions, and whether it is possible to modify synergy activations by means of specific therapies. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Technology-aided rehabilitation and Conventional rehabilitation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
132 participants
Where
2 sitesItaly
Study dates
1 Dec 2014to 1 Dec 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • diagnosis of first stroke;
  • a score between 1 and 3 (included) at the upper limb sub-item on the Italian version of the National Institute of Health stroke scale (IT - NIHSS) (Pezzella et al., 2009)
  • a score higher than 6 out of 66 on the Fugl - Meyer upper extremity (F-M UE) scale (Fugl-Meyer et al., 1975).

Who cannot join

  • the presence of a moderate cognitive decline defined as a Mini Mental State Examination (Folstein et al., 1975) score < 20/30 points;
  • the finding of severe verbal comprehension deficit defined as a number of errors > 13 (Tau Points < 58/78) on the Token Test (Huber et al., 1984);
  • evidence of apraxia and visuospatial neglect interfering with upper arm movements and manipulation of simple objects in all the directions within the visual field, as assessed through neurological examination;
  • report in the patient's clinical history or evidence from the neurological examination of behavioural disturbances (i.e. delusions, aggressiveness and severe apathy/depression) that could affect compliance with the rehabilitation programs;
  • non stabilised fractures;
  • diagnosis of depression/delusion;
Show all 11Show fewer
  • associated traumatic brain injury;
  • drug resistant epilepsy;
  • evidence of ideomotor apraxia;
  • evidence of visuospatial neglect;
  • severe impairment of verbal comprehension defined as a score higher than 13 errors on Token test (i.e. score<58 out of 78 Tau points).

Trial locations and contacts

2 sites in 1 country.

Italy2 sites
  • IRCCS Fondazione Don Gnocchi Onlus

    Milan

  • IRCCS San Camillo, Venezia, Italy

    Venice, 30126

Other trials in Italy

About this study

Official title: MOdularity for SEnsory Motor Control: Implications of Muscle Synergies in Motor Recovery After Stroke

For this project the investigators ask, how the activation and organization of muscle synergies may be disrupted by brain lesions, and whether it is possible to modify synergy activations by means of specific therapies. Will be investigated whether there is a relationship between post-stroke cortical plasticity and changes in synergy activations due to a therapy.

Read the detailed description

It has been widely recognized that neurorehabilitation can facilitate recovery of motor function after stroke. There has been increasing evidence suggesting that the execution of voluntary movement relies critically on the functional integration of the motor areas and the spinal circuitries. More precisely, it was suggested that the central nervous system may generate neural motor commands through a linear combination of spinal modules, each of which activates a group of muscles as a single unit (muscle synergy). The investigators hypothesize that descending motor cortical signals generate movements by combining and activating muscle synergies. With this background, the goal is to further improve the efficacy of rehabilitation utilizing knowledge on modular motor control. The investigators also seek to provide a better understanding of the links between brain activations and movements.

The project MO-SE has three aims, one primary and two secondary. The main primary aim is to test whether the use of virtual reality rehabilitation based therapies are superior in terms of clinical efficacy to conventional therapies (randomized clinica trial, RCT). The other two secondary aims of the project will be accomplished with further instrumental analysis in sub-samples of the group of patients enrolled for the RCT.

Being tested
Technology-aided rehabilitation, Conventional rehabilitation
Keywords
Muscle Synergies, MRI, Virtual Reality, Robotics
Medical subject headings
Ischemic Stroke, Arm Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Technology-aided rehabilitationDevice

    Also called Virtual Reality Rehabilitation System (VRRS), Braccio di Ferro

    VRRS involves performing different kinds of motor tasks with the patient holding a real manipulable object in their hands while interacting with a virtual scenario.

    "Braccio di Ferro" task consists in center-out reaching movements and return. The subject is required to start from a central target, reach one of five peripheral targets arranged on a semi-circle with a 20 cm radius and then return to the central target.

  • Conventional rehabilitationBehavioural

    The patients will be asked to perform a wide range of exercises, including: shoulder flexion-extension, abduction-adduction, internal-external rotation, circumduction, elbow flexion-extension, forearm pronation-supination, hand-digit motion. Standardized instructions and modalities will be followed when providing exercises to the patients in order to control for any variability in leading the therapy session due to the therapist.

Study groups in NCT03530358
Study groupRoleWhat they receive
Technology-aided rehabilitationExperimentalThe technology-aided upper limb rehabilitation include reinforced feedback in virtual environment (RFVE), or robotic therapy.
Receives: Device: Technology-aided rehabilitation
Conventional rehabilitationActive comparatorThe conventional upper limb rehabilitation program will be based on traditional rehabilitation techniques aimed at restoring upper limb motor functions.
Receives: Behavioral: Conventional rehabilitation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Fugl-Meyer Assessment Scale - Upper Extremity (construct: upper limb motor function)

    Scale range scores: 0 - 66 points. Total summed score is reported with higher values representing a better outcome.

    Measured: 20 days

Secondary outcomes (7)
  1. Functional Independence Measure (FIM) (construct: measure for independence in the activities of daily living - ADLs)

    Scale range scores: 18 - 126 points. Total summed score is reported with higher values representing a better outcome.

    Measured: 20 days

  2. Fugl-Meyer Assessment Scale - Range of Motion of Joints (construct: measure joints' passive range of motion)

    Scale range scores: 0 - 44 points. Total summed score is reported with higher values representing a better outcome.

    Measured: 20 days

  3. Fugl-Meyer Assessment Scale - Sensory Function (construct: measure of residual sensory function in upper and lower limbs affected by paresis)

    Scale range scores: 0 - 24 points. Total summed score is reported with higher values representing a better outcome.

    Measured: 20 days

  4. Fugl-Meyer Assessment Scale - Balance (construct: measure of impairment of standing and balance functions)

    Scale range scores: 0 - 14 points. Total summed score is reported with higher values representing a better outcome.

    Measured: 20 days

  5. Reaching Performance Scale (construct: measure of the ability to reach targets in the frontal space of upper limb affected by paresis)

    Scale range scores: 0 - 36 points. Total summed score is reported with higher values representing a better outcome.

    Measured: 20 days

  6. Modified Ashworth Scale (construct: measure of spasticity at the upper limb)

    Scale range scores: 0 - 5 ranks. Total summed ranks are reported with higher values representing a worse outcome.

    Measured: 20 days

  7. Box and Block Test

    Measure of gross motor function of the hand and upper limb

    Measured: 20 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 May 2018
  2. Study start1 Dec 2014
  3. Primary completion1 Dec 2018
  4. Study completion1 Dec 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized Clinical Trial
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
132 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03530358
Sponsor's protocol ID
2015.14
Other IDs
16/GR-2011-02348942
Acronym
MOSE
Status last verified
Jun 2022
First submitted
8 May 2018
Last updated
8 Jun 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Saltiel P, Wyler-Duda K, D'Avella A, Tresch MC, Bizzi E. Muscle synergies encoded within the spinal cord: evidence from focal intraspinal NMDA iontophoresis in the frog. J Neurophysiol. 2001 Feb;85(2):605-19. doi: 10.1152/jn.2001.85.2.605.

    PubMed 11160497
  • d'Avella A, Portone A, Fernandez L, Lacquaniti F. Control of fast-reaching movements by muscle synergy combinations. J Neurosci. 2006 Jul 26;26(30):7791-810. doi: 10.1523/JNEUROSCI.0830-06.2006.

    PubMed 16870725
  • Weiss T, Miltner WH, Liepert J, Meissner W, Taub E. Rapid functional plasticity in the primary somatomotor cortex and perceptual changes after nerve block. Eur J Neurosci. 2004 Dec;20(12):3413-23. doi: 10.1111/j.1460-9568.2004.03790.x.

    PubMed 15610174
  • Cheung VC, Piron L, Agostini M, Silvoni S, Turolla A, Bizzi E. Stability of muscle synergies for voluntary actions after cortical stroke in humans. Proc Natl Acad Sci U S A. 2009 Nov 17;106(46):19563-8. doi: 10.1073/pnas.0910114106. Epub 2009 Oct 30.

    PubMed 19880747
  • Cheung VC, Turolla A, Agostini M, Silvoni S, Bennis C, Kasi P, Paganoni S, Bonato P, Bizzi E. Muscle synergy patterns as physiological markers of motor cortical damage. Proc Natl Acad Sci U S A. 2012 Sep 4;109(36):14652-6. doi: 10.1073/pnas.1212056109. Epub 2012 Aug 20.

    PubMed 22908288
  • Mehrholz J, Hadrich A, Platz T, Kugler J, Pohl M. Electromechanical and robot-assisted arm training for improving generic activities of daily living, arm function, and arm muscle strength after stroke. Cochrane Database Syst Rev. 2012 Jun 13;(6):CD006876. doi: 10.1002/14651858.CD006876.pub3.

    PubMed 22696362
  • Laver KE, George S, Thomas S, Deutsch JE, Crotty M. Virtual reality for stroke rehabilitation. Cochrane Database Syst Rev. 2011 Sep 7;(9):CD008349. doi: 10.1002/14651858.CD008349.pub2.

    PubMed 21901720
  • Carpinella I, Cattaneo D, Abuarqub S, Ferrarin M. Robot-based rehabilitation of the upper limbs in multiple sclerosis: feasibility and preliminary results. J Rehabil Med. 2009 Nov;41(12):966-70. doi: 10.2340/16501977-0401.

    PubMed 19841825
  • Carpinella I, Cattaneo D, Bertoni R, Ferrarin M. Robot training of upper limb in multiple sclerosis: comparing protocols with or without manipulative task components. IEEE Trans Neural Syst Rehabil Eng. 2012 May;20(3):351-60. doi: 10.1109/TNSRE.2012.2187462.

    PubMed 22623407
  • Sacco RL, Wolf PA, Bharucha NE, Meeks SL, Kannel WB, Charette LJ, McNamara PM, Palmer EP, D'Agostino R. Subarachnoid and intracerebral hemorrhage: natural history, prognosis, and precursive factors in the Framingham Study. Neurology. 1984 Jul;34(7):847-54. doi: 10.1212/wnl.34.7.847.

    PubMed 6539860
  • Pezzella FR, Picconi O, De Luca A, Lyden PD, Fiorelli M. Development of the Italian version of the National Institutes of Health Stroke Scale: It-NIHSS. Stroke. 2009 Jul;40(7):2557-9. doi: 10.1161/STROKEAHA.108.534495. Epub 2009 Jun 11.

    PubMed 19520997
  • Keith RA, Granger CV, Hamilton BB, Sherwin FS. The functional independence measure: a new tool for rehabilitation. Adv Clin Rehabil. 1987;1:6-18. No abstract available.

    PubMed 3503663
  • Fugl-Meyer AR, Jaasko L, Leyman I, Olsson S, Steglind S. The post-stroke hemiplegic patient. 1. a method for evaluation of physical performance. Scand J Rehabil Med. 1975;7(1):13-31.

    PubMed 1135616
  • Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189-98. doi: 10.1016/0022-3956(75)90026-6. No abstract available.

    PubMed 1202204
  • Huber W, Poeck K, Willmes K. The Aachen Aphasia Test. Adv Neurol. 1984;42:291-303. No abstract available.

    PubMed 6209953

Questions about this trial

What is this clinical trial studying?

A study testing Technology-aided rehabilitation and Conventional rehabilitation in people with Stroke, Ischemic and Upper Limb Injury, run by IRCCS San Camillo, Venezia, Italy at 2 sites in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 8 Jun 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Fugl-Meyer Assessment Scale - Upper Extremity (construct: upper limb motor function) (time frame: 20 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03530358, which also lists 28 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jun 2022.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in